November 29 (SeeNews) - Bulgarian drug maker Sopharma [BUL:3JR] said on Wednesday its consolidated net profit rose to 32.7 million levs ($19.8 million/16.7 million euro) in the first nine months of 2017, from 31.6 million levs in the like period of 2016.